Filippo Acconcia

Filippo Acconcia

Sep 19, 2017

Group 6 Copy 34
1
Please wait...

About This Project

70% of breast cancers are estrogen receptor α (ERα)-positive. ERα is the antenna that senses the ovarian hormone estrogen (E2) and drives tumour cell proliferation and spreading. 4OH-tamoxifen and faslodex are given to patients to prevent cancer growth and spreading but they possess serious side effects. Thus, additional drugs are needed to fight breast cancer. We will explore existing drugs for the possibility of ‘reuse’ as breast cancer drugs.

More Lab Notes From This Project

Blast off!

Browse Other Projects on Experiment

Related Projects

How does taking Ritalin affect depersonalization-derealization disorder patients?

We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...

Developing a new tissue preservation method inspired by Tardigrades

There are two routine ways to preserve tissues: formalin-fixed paraffin-embedded preservation (FFPE) and...

Targeted Drug Delivery by using Magnetic Nanoparticles

What if we could use a novel approach for delivering currently injectable drugs to the body without syringes...

Campaign Ended